Delivery Order SPE2DB22D3016-SPE2DB25FBFC1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 15, 2025, for Rectiv 0.4% Ointment in 30-gram quantities, with a ceiling value of $3,515.21. This firm fixed-price delivery order, which will be completed by May 16, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation, and performance will occur at...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Rectiv 0.4% Ointment in 30-gram units. This firm fixed-price delivery order, valued at $2,833.45, was competitively awarded without a set-aside designation and carries an ultimate completion date of September 17, 2025. The place of performance is located at AmerisourceBergen's corporate office in...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RECTIV 0.4% OINTMENT 30GM, a pharmaceutical product, with a ceiling value of $1,955.39. The contract has a firm fixed price pricing type and an ultimate completion date of May 19, 2025. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not set aside....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,062.14 firm fixed-price delivery order is for the supply of 4566134271 - RECTIV 0.4% OINTMENT 30GM, with a completion date of October 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- The Defense Logistics Agency awarded a $5,040.88 delivery order contract to Amerisourcebergen Drug Corporation for the supply of 4561958976 Rectiv 0.4% Ointment 30gm. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the specified pharmaceutical product to a location in Conshohocken, Pennsylvania under a firm fixed price contract structure. The single delivery is to be completed by August 29, 2023 to support the Defense Logistics Agency's medical supply chain programs....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RECTIV 0.4% ointment, a pharmaceutical product, with a ceiling value of $2,023.15. The contract is a firm-fixed price type with a period of performance through May 7, 2025. The place of performance is Conshohocken, Pennsylvania. This contract is not associated with a set-aside...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide RECTIV 0.4% ointment. This $7,587.34 award is part of a larger $999,999,999.00 indefinite delivery contract (IDC) with AmerisourceBergen Drug Corp to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department...
- The Defense Logistics Agency awarded a $5,425 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562055038 RECTIV 0.4% Ointment 30gm. The single award was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day, from September 5-6, 2023. No subcontractors or...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on June 2, 2025, for Relistor 150 mg tablets (90-count) valued at $3,332.28. This firm fixed-price delivery order, with an ultimate completion date of June 3, 2025, was competitively awarded without set-aside designation. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for ORSERDU 345 mg tablets in a 30-count package. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $27,841.82 with an ultimate completion date of August 11, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBFC1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for Rectiv 0.4% Ointment in 30-gram units, with a firm fixed price ceiling value of $1,570.88 and an ultimate completion date of August 18, 2025. This competitively awarded, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's medical supply chain. This delivery order is part of AmerisourceBergen's extensive portfolio of pharmaceutical supply contracts with the federal government. The company holds a prime indefinite delivery vehicle valued at $999,999,999.00 with DLA Troop Support Medical through December 2026, which enables the delivery of a comprehensive range of pharmaceuticals, medical supplies, and specialty medications to support military healthcare programs globally. The company's proven track record of fulfilling federal medical procurement requirements through open competition, combined with its capability to manage both small-value transactions and substantial orders, positions it as a key supplier within the Defense Health Agency's pharmaceutical distribution network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/15/25 |